L. Liefeldt et al., Transgenic rats expressing the human ET-2 gene: a model for the study of endothelin actions in vivo, J MOL MED-J, 77(7), 1999, pp. 565-574
Citations number
58
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Previous studies have characterized the endothelin peptides (ET-1, ET-2, ET
-3) as strong vasoconstrictors which are possibly involved in the pathogene
sis of cardiovascular disease. Whereas ET-1 and ET-3 have been characterize
d using a number of approaches, little is known about the function of ET-2.
The aim of this study was to define the role of ET-2 in physiology and pat
hophysiology using a transgenic approach. Transgenic rats expressing a geno
mic construct of the human ET-2 gene were generated by microinjection of fe
rtilized oocytes from Sprague-Dawley rats. Two transgenic lines were genera
ted, and one line was further characterized in detail. Studies on mRNA expr
ession demonstrated that the transgene is expressed predominantly in kidney
, gastrointestinal tract, adrenal gland, lung, and brain. Plasma endothelin
levels were elevated 2-fold, and big-endothelin levels were elevated 2.5-f
old. Despite these-alterations blood pressure in transgenic rats remained n
ormal. Further analysis of transgenic animals revealed that endothelin rece
ptors were not downregulated, and that infusion of exogenous human ET-2 res
ults in an enhanced blood pressure response. These observations suggest the
presence of counterregulatory mechanisms influencing the effects of endoth
elin on blood pressure. One of these mechanisms may involve the nitric oxid
e system since infusion of an inhibitor of nitric oxide synthase resulted i
n a greater blood pressure response than in nontransgenic littermates. Desp
ite unchanged blood pressure, alterations were observed in organ developmen
t and function, namely of hearts and kidneys, indicating an interference be
tween transgene expression and growth processes. Male rats seem to be more
susceptible to endothelin actions. These data show that the elevation in en
dothelin-2 expression in this transgenic model does not induce hypertension
but leads to changes at the end-organ level. Normotension is most likely d
ue to compensatory mechanisms such as increased nitric oxide formation.